Clinical Trials Logo

Bone Diseases clinical trials

View clinical trials related to Bone Diseases.

Filter by:

NCT ID: NCT04356807 Completed - Clinical trials for Metabolic Bone Disease

Physical Therapy to Prevent Osteopenia in Preterm Infants

Start date: February 2016
Phase: N/A
Study type: Interventional

To determine whether reflex locomotion therapy is effective for the prevention of osteopenia in preterm infants and compare its effectiveness over other physiotherapeutic methods like passive joint mobilizations and massage

NCT ID: NCT04208230 Completed - Type 2 Diabetes Clinical Trials

Progression and Etiology of Cortical Porosity in Diabetic Bone Disease

PREPT2D
Start date: January 3, 2017
Phase:
Study type: Observational

Type 2 diabetes is associated with increased cortical bone porosity and increased fracture risk. The goal of this proposed study is to understand the longitudinal evolution of cortical bone porosity and to investigate the underlying biological processes that drive increased cortical porosity and fracture risk in the setting of diabetes. The investigators will apply novel techniques for in vivo imaging of cortical pores to patients with type 2 diabetes and controls in a longitudinal prospective study. This work will establish the longitudinal progression of cortical porosity and determine whether pore content can serve as a predictor of future cortical degradation and bone fragility.

NCT ID: NCT04093856 Completed - Obesity Clinical Trials

Determinants of Bone and Muscle Quality and Strength in Obesity With and Without Diabetes

BODI2
Start date: January 14, 2020
Phase:
Study type: Observational

Background: Osteoporotic fractures are a major public health issue. They cause substantial disability, loss of autonomy, morbidity and excess mortality. Diabetes is also associated with increased risk for falls and fractures through a direct impact of elevated blood glucose on the skeleton and on muscles. Research project overview: The investigators propose a cross-sectional study that will involve 2 research centers in the province of Quebec. The investigators will recruit 20 obese participants, without diabetes, who have not undergone bariatric surgery, for one-time measurements to be compared with baseline measurements (pre-surgery) from participants in the bariatric obese diabetic groups with type II diabetes mellitus from the ongoing study BODI study (NCT03455868). Bone Mineral Density as well as muscle quality, strength and function will be evaluated at a single study visit. Relevance: This data will permit the evaluation of the bone-muscle unit in patients with obesity with and without diabetes, and assess whether the presence and duration of diabetes impacts further on clinical and functional musculoskeletal outcomes (falls, fractures and mobility and strength) in this population. AGEs, if associated with muscle and bone deterioration, might become an easily accessible biomarker of musculoskeletal health in the clinical setting.

NCT ID: NCT03960437 Completed - Clinical trials for Vascular Calcification

The Effect of Etelcalcetide on CKD-MBD

Parsabiv-MBD
Start date: September 6, 2018
Phase: Phase 2
Study type: Interventional

The proposed study will investigate the effects of etelcalcetide on the bone and blood-vessel health in patients with CKD-MBD. The investigators will test if etelcalcetide makes bone and blood-vessels healthier. The study hypotheses are that are that etelcalcetide keeps bones strong and lowers the risk of calcium deposits in blood vessels. In Aim 1, the investigators will test if 9-months of treatment with etelcalcetide improves bone strength in twenty ESKD patients with hyperparathyroidism (HPT) by bone biopsy. In Aim 2, the investigators will test if 9-months of treatment with etelcalcetide decreases serum propensity to calcify blood vessels. The potential significance of this study is to provide first-time data on the ability of etelcalcetide to protect bone and blood-vessel health in patients with ESKD.

NCT ID: NCT03958409 Completed - Clinical trials for Kidney Transplant; Complications

Evaluation and Management of Metabolic Bone Disease in Kidney Transplant Recipients

Start date: December 12, 2018
Phase: N/A
Study type: Interventional

There is a well-documented increased risk for disordered mineral bone homeostasis in Kidney Transplant Recipients (KTRs) when compared to the general population, leading to a markedly increased risk for fragility fractures and their associated morbidity and mortality. A more uniform and rigorous evaluation of bone and mineral homeostasis,than is afforded to patients under "normal care", will result in better clinical outcomes in KTRs.

NCT ID: NCT03937349 Completed - Clinical trials for Secondary Hyperparathyroidism

Impact of Parathyroidectomy on Cardiovascular Calcification in Dialysis-dependent Patients

Start date: May 14, 2019
Phase:
Study type: Observational

This is a prospective cohort study aimed to evaluate change of cardiovascular calcification after parathyroidectomy in patients with end-stage renal disease on dialysis compared with control group on conservative treatment.

NCT ID: NCT03878134 Completed - Cancer Clinical Trials

Translational Development of Photon-counting CT Imaging

Start date: October 1, 2019
Phase: N/A
Study type: Interventional

Using an investigational CT scanner which uses a new type of detector to capture X-rays, (a photon counting CT detector), the goal of this experimental study is to compare conventional CT images to CT images using the photon counting detector in patients undergoing CT scans for clinically indicated reasons. The main question it aims to answer is whether the images produced using the new detectors are superior in quality. Participants will undergo the clinically indicated CT images and the photon counting detector CT images of a limited area during the same examination time.

NCT ID: NCT03811873 Completed - Clinical trials for Transplant-Related Disorder

Assessment of Vertebral Fracture Risk for First Time Liver Transplant Candidates

VFA
Start date: February 18, 2019
Phase: N/A
Study type: Interventional

The researchers are trying to compare the effectiveness of Vertebral Fracture Assessment (VFA) in addition to the current standard of care spine x-ray in evaluation pre-liver transplant patients.

NCT ID: NCT03746717 Completed - Clinical trials for Metastatic Bone Disease of the Proximal Femur

Occlusive Skin Closure May Reduce Wound Drainage After Tumor Hip Arthroplasty

Start date: January 15, 2017
Phase: N/A
Study type: Interventional

Study Type: Investigator initiated, non-significant risk Study Objective(s): To establish the effect of occlusive wound closure with the DERMABONDTM PRINEO skin closure system, compared to routine wound closure with skin staples, on post-operative wound discharge (PWD) after tumor arthroplasty of the hip Study Population: Patients with secondary tumors of bone, undergoing tumor resection and primary endoprosthetic reconstruction involving the hip joint Inclusion Criteria: - Bone resection and endoprosthetic reconstruction for metastatic bone lesions involving the proximal femur or acetabulum - Imminent, or de-facto pathologic fractures of proximal femur and/or acetabulum, requiring endoprosthetic reconstruction (with or without bone resection) involving the hip joint Exclusion Criteria: - Minors - Pregnant and breast-feeding women - Skin defects and wound conditions not amenable to primary wound closure and other DERMABOND PRINEO contraindications - Underlying infection - Total femur replacements - Implant revision procedures Structure: Open 2-arm prospective randomized controlled trial. Duration of Study: 18 -24 months Multi-center: No Masking/Blinding: No Method of Subject Assignment: Block Randomization (10 in each block) Concurrent Control: Active - wound closure with skin staples Estimated Total Sample Size: 70 subjects will be enrolled in this study Statistical Rationale Provided: Yes Statistical Methods: Student t test for unpaired data Study Endpoints: - Time to dry wound status (in post-operative days) - Duration of antibiotic use (in post-operative days) - Length of hospital stay (in post-operative days)

NCT ID: NCT03698422 Completed - Clinical trials for Chronic Kidney Diseases

Diurnal Variation in Markers of Mineral and Bone Disease in Chronic Kidney Disease

Start date: October 3, 2018
Phase:
Study type: Observational

The purpose of this study is to examine whether there are diurnal variations in magnesium and other markers related to mineral metabolism in blood from patients with chronic kidney disease (CKD) compared to healthy controls.